NCT04979312Withdrawn
Glucose and Blood Pressure During Pregnancy
Predictive Role of Non-Invasive Glucose Assessment During Pregnancy: A Pilot Study
Source: ClinicalTrials.gov · Last updated 15 Sept 2026
Brief summary (registry, in English)
The purpose of this research is to examine the beneficial effects of regular, non-invasive, glucose (sugar) assessment on glucose (sugar) and blood pressure regulation during pregnancy to help in predicting gestational diabetes and preeclampsia.
- Status (registry)
- Withdrawn
- Study type
- Interventional
- Enrollment
- 0 (actual)
- First submitted
- 14 Jul 2021
- Start date
- Aug 2026
- Primary completion date
- Jan 2027
- Lead sponsor
- Mayo Clinic
- Diseases
- High blood pressure
- NCT number
- NCT04979312
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Lab values
- Presence of chronic kidney disease (creatinine >2.5mg/dL) and/or active cancer
- Use of chronic medications which influence blood [glucose] or [insulin]
Other
- Smoking
- Multiple pregnancies
- Congenital abnormalities
- Subsequent diagnosis of GDM or preeclampsia
Who the study is looking for
- Age range: 18-45 years (inclusive)
- Body mass index (BMI) ≤40kg/m2
- >1 risk factor for GDM
- <16wks gestation
- Gender: only females will be recruited into this study
- Ability to provide written informed consent
Age in the registry: 18 years to 45 years · Sex: Female · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Mayo Clinic Coordinator of this site? Confirm its status | Rochester | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.